Paper Details

  1. Home
  2. Paper Details

Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma.

Author: BarnesPeter J, ErinEdward M, HanselTrevor T, MausJoachim G, NeighbourHelen, TanAndrew J, TennantRachel C

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Inhaled anticholinergic drugs are effective bronchodilators in the treatment of COPD. Tiotropium bromide is a once-daily bronchodilator used for maintenance treatment. Racemic glycopyrrolate is another anticholinergic drug that has been studied for use in asthma and COPD.
Paper Details　
Original Abstract of the Article :
Inhaled anticholinergic drugs are effective bronchodilators in the treatment of COPD, and tiotropium bromide has recently been introduced as a once-daily bronchodilator for use as a maintenance treatment. Racemic glycopyrrolate is an anticholinergic drug that has been used orally to control gastric ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1378/chest.128.4.1974

データ提供：米国国立医学図書館（NLM）

Glycopyrrolate: A Long-Acting Bronchodilator

The treatment of asthma involves a delicate balance between managing symptoms and minimizing side effects. This research explores the potential of glycopyrrolate, an anticholinergic drug, as a long-acting bronchodilator for patients with asthma. The authors found that glycopyrrolate provides prolonged bronchoprotection and bronchodilation, offering a potential alternative to existing treatments. It's like discovering a new oasis in the vast desert of asthma treatment, providing a reliable source of relief for those seeking long-term symptom control.

Expanding the Horizon of Asthma Treatment

This study provides a comprehensive overview of glycopyrrolate's potential as a bronchodilator for asthma. The authors' findings suggest that this anticholinergic drug offers prolonged bronchoprotection and bronchodilation, opening up new avenues for long-term asthma management. It's like finding a new route through the desert, offering a more sustainable path towards asthma control.

Breathing Easy in the Asthma Desert

The discovery of glycopyrrolate's long-acting bronchodilator properties is a significant development in asthma treatment. This drug could provide patients with a more sustained and effective way to manage their symptoms, allowing them to breathe easier and live fuller lives. It's like discovering a cool spring in the heart of the desert, offering a much-needed respite from the harsh realities of asthma.

Dr.Camel's Conclusion

The study on glycopyrrolate highlights the ongoing search for better treatments for asthma. This research sheds light on the potential of this anticholinergic drug as a long-acting bronchodilator, offering a promising new option for patients seeking sustained relief. It's like finding a new path through the desert, leading to a more comfortable and manageable journey for those with asthma.
Date :
  1. Date Completed 2005-11-21
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

16236844

DOI: Digital Object Identifier

10.1378/chest.128.4.1974

Related Literature

Article Analysis
・Effects of glycopyrrolate oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.